Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Gastroenterol Hepatol

Retrieve available abstracts of 29 articles:
HTML format

Single Articles

    February 2023
  1. MARTINEZ RAMIREZ NM, Gonzalez Praetorius A, Martinez Benito Y, Garcia Rivera MV, et al
    Changes in the epidemiology of hepatitis A: Clinical and preventive implications.
    Gastroenterol Hepatol. 2023;46:116-123.
    PubMed     Abstract available

    January 2023
  2. FRAILE-LOPEZ M, Alvarez-Navascues C, Gonzalez-Dieguez ML, Cadahia V, et al
    Predictive models for hepatocellular carcinoma development after sustained virological response in advanced hepatitis C.
    Gastroenterol Hepatol. 2023 Jan 27:S0210-5705(23)00013.
    PubMed     Abstract available

  3. NEOKOSMIDIS G, Protopapas AA, Stogiannou D, Filippidis A, et al
    Cardiometabolic effects of direct-acting antivirals in patients with hepatitis C.
    Gastroenterol Hepatol. 2023;46:58-66.
    PubMed     Abstract available

  4. SHARKAWI FZE, El-Sherbiny M, Ali SAM, Nassif WMH, et al
    The potential value of plasma Circ-ITCH in hepatocellular carcinoma patients with current hepatitis C virus infection.
    Gastroenterol Hepatol. 2023;46:17-27.
    PubMed     Abstract available

    December 2022
  5. MARTINEZ-CAMPRECIOS J, Riveiro-Barciela M, Munoz-Gomez R, Londono MC, et al
    [Not Available].
    Gastroenterol Hepatol. 2022 Dec 27:S0210-5705(22)00313.

    November 2022
  6. GARRIDO-ESTEPA M, Herruzo R, Flores-Herrera J
    Co-infections, comorbidities, and alcohol or other substances abuses in chronic hepatitis C-related hospitalisations in Spain.
    Gastroenterol Hepatol. 2022;45:677-689.
    PubMed     Abstract available

    October 2022
  7. CRESPO J, Cabezas J, Aguilera A, Berenguer M, et al
    Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction.
    Gastroenterol Hepatol. 2022 Oct 15. pii: S0210-5705(22)00235.

  8. CUNHA-SILVA M, Torres LD, Fernandes MF, Secundo TML, et al
    Changes in indications for outpatient percutaneous liver biopsy over 5 years: from hepatitis C to fatty liver disease.
    Gastroenterol Hepatol. 2022;45:579-584.
    PubMed     Abstract available

    August 2022
  9. LAVIN AC, Cabezas J, Crespo J
    Letter to the editor in response to the recently published article "Roncero C, Buch B, Martin-Sanchez AM, et al. Prevalence of hepatitis C virus infection in patients with chronic mental disorders: the relevance of dual diagnosis. Gastroenterol Hepato
    Gastroenterol Hepatol. 2022 Aug 11. pii: S0210-5705(22)00183.

    June 2022
  10. RONCERO C, Buch B, Martin-Sanchez AM, Alvarez-Navares AI, et al
    Prevalence of hepatitis C virus infection in patients with chronic mental disorders: the relevance of dual diagnosis.
    Gastroenterol Hepatol. 2022 Jun 30. pii: S0210-5705(22)00172.
    PubMed     Abstract available

  11. GUTIERREZ-ROJAS L, de la Gandara Martin JJ, Garcia Buey L, Uriz Otano JI, et al
    Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: results of a literature review.
    Gastroenterol Hepatol. 2022 Jun 16. pii: S0210-5705(22)00164.
    PubMed     Abstract available

    May 2022
  12. ANDRES L, Badia E, Fernandez C, Puebla A, et al
    Gastroenterol Hepatol. 2022 May 13. pii: S0210-5705(22)00150.

  13. CHEN M, Wu Z, Du Z, Sun S, et al
    Diagnostic accuracy of red blood cell distribution width to platelet ratio for predicting liver fibrosis in patients with chronic hepatitis B: A meta-analysis.
    Gastroenterol Hepatol. 2022;45:361-372.
    PubMed     Abstract available

    April 2022
  14. TORRENTE S, Castiella A, Garmendia M, Zapata E, et al
    Probable autoimmune hepatitis reactivated after COVID-19 vaccination.
    Gastroenterol Hepatol. 2022;45 Suppl 1:115-116.

  15. MACIA-RODRIGUEZ C, Santome Couto L, Fernandez Villaverde A, Romero Reinoso C, et al
    Mycophenolate mofetil as a treatment of severe steroid-resistant immune-related hepatitis.
    Gastroenterol Hepatol. 2022;45 Suppl 1:32-36.

    March 2022
  16. NUNEZ F P, Quera R, Bay C, Thomson P, et al
    Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases.
    Gastroenterol Hepatol. 2022;45:223-230.
    PubMed     Abstract available

  17. PEREZ JIMENEZ RD, Granados Monzon R, Hernandez Febles M, Pena Lopez MJ, et al
    Acute hepatitis due to the hepatitisC virus: Where are the transmission occurring?
    Gastroenterol Hepatol. 2022;45:192-197.
    PubMed     Abstract available

    February 2022
  18. ARANDA EB, Marcos CF, Maestu AP, Marin VG, et al
    Gastroenterol Hepatol. 2022 Feb 18. pii: S0210-5705(22)00064.
    PubMed     Abstract available

  19. RASHIDI A, Sedaghat F, Nejat A, Azarpira N, et al
    Immunity to hepatitis A virus in liver transplant recipients: A population-based study in Iran.
    Gastroenterol Hepatol. 2022;45:99-105.
    PubMed     Abstract available

  20. ROCHA HC, Vilela EG
    Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases.
    Gastroenterol Hepatol. 2022;45:83-90.
    PubMed     Abstract available

    December 2021
  21. OLIVAS I, Cobreros M, Londono MC, Diaz-Gonzalez A, et al
    Budesonide in the first line treatment of patients with autoimmune hepatitis.
    Gastroenterol Hepatol. 2021 Dec 16. pii: S0210-5705(21)00319.
    PubMed     Abstract available

    October 2021
  22. CALVET X, Carpio D, Rodriguez-Lago I, Garcia-Vicuna R, et al
    Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies.
    Gastroenterol Hepatol. 2021;44:587-598.
    PubMed     Abstract available

    September 2021
  23. GARCIA-FRAILE LJ, Garcia-Buey L, Cerezo CA, Sanz JS, et al
    ENGLISH: Evolution of HCV associated Porphyria Cutanea Tarda after HCV Sustained Virologic Response by Direct Acting Antivirals.
    Gastroenterol Hepatol. 2021 Sep 22. pii: S0210-5705(21)00248.
    PubMed     Abstract available

  24. DE CANETE CAMACHO JCF, Martinez AM, Mena MAG, Maria Moreno Planas J, et al
    Influence of psychiatric disorders and opioid substitution therapy on hepatitis c treatment with direct-acting antivirals in people who inject drugs.
    Gastroenterol Hepatol. 2021 Sep 17. pii: S0210-5705(21)00251.
    PubMed     Abstract available

  25. CAMARERO JG, Aranda EB, Castro RQ, Chumillas RMS, et al
    Hepatitis B And C Screening In Hospitalized Patients With Sars-Cov-2 Infection.
    Gastroenterol Hepatol. 2021 Sep 8. pii: S0210-5705(21)00250.
    PubMed     Abstract available

    June 2021
  26. TURNES J, Rincon D, Calleja JL, Delgado MB, et al
    Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naive non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study.
    Gastroenterol Hepatol. 2021 Jun 12. pii: S0210-5705(21)00198.
    PubMed     Abstract available

    May 2021
  27. REYGOSA C, Arraez DM, Hernandez-Bustabad A, Baute LM, et al
    Hepatitis C-Treated Patients As A Potential Source For Referral Of New Cases.
    Gastroenterol Hepatol. 2021 May 20. pii: S0210-5705(21)00148.
    PubMed     Abstract available

    April 2021
  28. BUSTA NISTAL MR, Garcia Sanchez MC, Mora Cuadrado N, Dura Gil M, et al
    Cholestatic hepatitis as a presentation of secondary syphilis.
    Gastroenterol Hepatol. 2021 Apr 16. pii: S0210-5705(21)00117.

  29. COSTA CA, Garcia JLR, Gandia MAR, Martos RF, et al
    Gastroenterol Hepatol. 2021 Apr 13. pii: S0210-5705(21)00118.

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.